Comparison of retinal vasodilator and constrictor responses in type 2 diabetes

Mary E.J. Lott, Julia E. Slocomb, Vikram Shivkumar, Bruce Smith, Robert A. Gabbay, David Quillen, Thomas W. Gardner, Kerstin Bettermann

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Purpose: The retinal blood vessels provide a unique way to directly examine the human microvasculature, which is frequently damaged in individuals with diabetes. Previous studies have demonstrated that retinal flickering light-induced vasodilation and hyperoxia-induced vasoconstriction may operate by enhancing or reducing similar vasoregulatory factor(s), but a comparison between these two provocative stimuli in individuals with diabetes has not been studied. The purpose of the study was to examine the association between retinal flickering light-induced vasodilation and retinal hyperoxia-induced vasoconstriction in type 2 diabetic subjects and in healthy controls. Methods: Twenty men and women with type 2 diabetes and 10 men and women without diabetes between 21 and 75 years of age were recruited. Changes in retinal artery and vein diameters to flickering light and during hyperoxia (100% oxygen) stimuli were measured on the same visit using a noninvasive retinal imaging device (Dynamic Vessel Analyzer, Imedos Inc., Germany). Results: Compared with controls, diabetic subjects had impaired arterial vasodilator and vasoconstrictor responses to both flickering light and hyperoxia, respectively (both p < 0.001). Merging both groups, an inverse correlation (r = -0.56; p = 0.003) between the retinal artery's responses to flickering light-induced vasodilation and hyperoxia-induced vasoconstriction was demonstrated independent of glucose or insulin levels. Conclusion: This suggests that both responses are attenuated to a similar degree in diabetic subjects and that the attenuation to both stimuli can be observed in retinal arteries and veins. This would suggest that similar vasoregulatory factor(s) might in part help to explain the retinal diameter responses between the two stimuli. One suggested common vasoregulator of vascular tone is nitric oxide; however, other factor(s) may be involved, which contribute to this association and require further research.

Original languageEnglish (US)
Pages (from-to)e434-e441
JournalActa Ophthalmologica
Volume90
Issue number6
DOIs
StatePublished - Sep 1 2012

Fingerprint

Hyperoxia
Vasodilator Agents
Type 2 Diabetes Mellitus
Retinal Artery
Light
Vasoconstriction
Vasodilation
Retinal Vein
Retinal Vessels
Vasoconstrictor Agents
Microvessels
Germany
Blood Vessels
Healthy Volunteers
Nitric Oxide
Insulin
Oxygen
Glucose
Equipment and Supplies
Research

All Science Journal Classification (ASJC) codes

  • Ophthalmology

Cite this

Lott, Mary E.J. ; Slocomb, Julia E. ; Shivkumar, Vikram ; Smith, Bruce ; Gabbay, Robert A. ; Quillen, David ; Gardner, Thomas W. ; Bettermann, Kerstin. / Comparison of retinal vasodilator and constrictor responses in type 2 diabetes. In: Acta Ophthalmologica. 2012 ; Vol. 90, No. 6. pp. e434-e441.
@article{bd4bd03f41f44b119ddabedc0eaae249,
title = "Comparison of retinal vasodilator and constrictor responses in type 2 diabetes",
abstract = "Purpose: The retinal blood vessels provide a unique way to directly examine the human microvasculature, which is frequently damaged in individuals with diabetes. Previous studies have demonstrated that retinal flickering light-induced vasodilation and hyperoxia-induced vasoconstriction may operate by enhancing or reducing similar vasoregulatory factor(s), but a comparison between these two provocative stimuli in individuals with diabetes has not been studied. The purpose of the study was to examine the association between retinal flickering light-induced vasodilation and retinal hyperoxia-induced vasoconstriction in type 2 diabetic subjects and in healthy controls. Methods: Twenty men and women with type 2 diabetes and 10 men and women without diabetes between 21 and 75 years of age were recruited. Changes in retinal artery and vein diameters to flickering light and during hyperoxia (100{\%} oxygen) stimuli were measured on the same visit using a noninvasive retinal imaging device (Dynamic Vessel Analyzer, Imedos Inc., Germany). Results: Compared with controls, diabetic subjects had impaired arterial vasodilator and vasoconstrictor responses to both flickering light and hyperoxia, respectively (both p < 0.001). Merging both groups, an inverse correlation (r = -0.56; p = 0.003) between the retinal artery's responses to flickering light-induced vasodilation and hyperoxia-induced vasoconstriction was demonstrated independent of glucose or insulin levels. Conclusion: This suggests that both responses are attenuated to a similar degree in diabetic subjects and that the attenuation to both stimuli can be observed in retinal arteries and veins. This would suggest that similar vasoregulatory factor(s) might in part help to explain the retinal diameter responses between the two stimuli. One suggested common vasoregulator of vascular tone is nitric oxide; however, other factor(s) may be involved, which contribute to this association and require further research.",
author = "Lott, {Mary E.J.} and Slocomb, {Julia E.} and Vikram Shivkumar and Bruce Smith and Gabbay, {Robert A.} and David Quillen and Gardner, {Thomas W.} and Kerstin Bettermann",
year = "2012",
month = "9",
day = "1",
doi = "10.1111/j.1755-3768.2012.02445.x",
language = "English (US)",
volume = "90",
pages = "e434--e441",
journal = "Acta Ophthalmologica",
issn = "1755-375X",
publisher = "Wiley-Blackwell",
number = "6",

}

Comparison of retinal vasodilator and constrictor responses in type 2 diabetes. / Lott, Mary E.J.; Slocomb, Julia E.; Shivkumar, Vikram; Smith, Bruce; Gabbay, Robert A.; Quillen, David; Gardner, Thomas W.; Bettermann, Kerstin.

In: Acta Ophthalmologica, Vol. 90, No. 6, 01.09.2012, p. e434-e441.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Comparison of retinal vasodilator and constrictor responses in type 2 diabetes

AU - Lott, Mary E.J.

AU - Slocomb, Julia E.

AU - Shivkumar, Vikram

AU - Smith, Bruce

AU - Gabbay, Robert A.

AU - Quillen, David

AU - Gardner, Thomas W.

AU - Bettermann, Kerstin

PY - 2012/9/1

Y1 - 2012/9/1

N2 - Purpose: The retinal blood vessels provide a unique way to directly examine the human microvasculature, which is frequently damaged in individuals with diabetes. Previous studies have demonstrated that retinal flickering light-induced vasodilation and hyperoxia-induced vasoconstriction may operate by enhancing or reducing similar vasoregulatory factor(s), but a comparison between these two provocative stimuli in individuals with diabetes has not been studied. The purpose of the study was to examine the association between retinal flickering light-induced vasodilation and retinal hyperoxia-induced vasoconstriction in type 2 diabetic subjects and in healthy controls. Methods: Twenty men and women with type 2 diabetes and 10 men and women without diabetes between 21 and 75 years of age were recruited. Changes in retinal artery and vein diameters to flickering light and during hyperoxia (100% oxygen) stimuli were measured on the same visit using a noninvasive retinal imaging device (Dynamic Vessel Analyzer, Imedos Inc., Germany). Results: Compared with controls, diabetic subjects had impaired arterial vasodilator and vasoconstrictor responses to both flickering light and hyperoxia, respectively (both p < 0.001). Merging both groups, an inverse correlation (r = -0.56; p = 0.003) between the retinal artery's responses to flickering light-induced vasodilation and hyperoxia-induced vasoconstriction was demonstrated independent of glucose or insulin levels. Conclusion: This suggests that both responses are attenuated to a similar degree in diabetic subjects and that the attenuation to both stimuli can be observed in retinal arteries and veins. This would suggest that similar vasoregulatory factor(s) might in part help to explain the retinal diameter responses between the two stimuli. One suggested common vasoregulator of vascular tone is nitric oxide; however, other factor(s) may be involved, which contribute to this association and require further research.

AB - Purpose: The retinal blood vessels provide a unique way to directly examine the human microvasculature, which is frequently damaged in individuals with diabetes. Previous studies have demonstrated that retinal flickering light-induced vasodilation and hyperoxia-induced vasoconstriction may operate by enhancing or reducing similar vasoregulatory factor(s), but a comparison between these two provocative stimuli in individuals with diabetes has not been studied. The purpose of the study was to examine the association between retinal flickering light-induced vasodilation and retinal hyperoxia-induced vasoconstriction in type 2 diabetic subjects and in healthy controls. Methods: Twenty men and women with type 2 diabetes and 10 men and women without diabetes between 21 and 75 years of age were recruited. Changes in retinal artery and vein diameters to flickering light and during hyperoxia (100% oxygen) stimuli were measured on the same visit using a noninvasive retinal imaging device (Dynamic Vessel Analyzer, Imedos Inc., Germany). Results: Compared with controls, diabetic subjects had impaired arterial vasodilator and vasoconstrictor responses to both flickering light and hyperoxia, respectively (both p < 0.001). Merging both groups, an inverse correlation (r = -0.56; p = 0.003) between the retinal artery's responses to flickering light-induced vasodilation and hyperoxia-induced vasoconstriction was demonstrated independent of glucose or insulin levels. Conclusion: This suggests that both responses are attenuated to a similar degree in diabetic subjects and that the attenuation to both stimuli can be observed in retinal arteries and veins. This would suggest that similar vasoregulatory factor(s) might in part help to explain the retinal diameter responses between the two stimuli. One suggested common vasoregulator of vascular tone is nitric oxide; however, other factor(s) may be involved, which contribute to this association and require further research.

UR - http://www.scopus.com/inward/record.url?scp=84865679604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865679604&partnerID=8YFLogxK

U2 - 10.1111/j.1755-3768.2012.02445.x

DO - 10.1111/j.1755-3768.2012.02445.x

M3 - Article

C2 - 22682034

AN - SCOPUS:84865679604

VL - 90

SP - e434-e441

JO - Acta Ophthalmologica

JF - Acta Ophthalmologica

SN - 1755-375X

IS - 6

ER -